These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5755195)

  • 1. [Liver damage in tuberculosis].
    Pickroth G
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):265-70. PubMed ID: 5755195
    [No Abstract]   [Full Text] [Related]  

  • 2. [Centrilobular liver necrosis following antimycobacterial treatment].
    Beckert W
    Z Erkr Atmungsorgane Folia Bronchol; 1971 Aug; 135(1):11-7. PubMed ID: 5209484
    [No Abstract]   [Full Text] [Related]  

  • 3. [Centrilobular parenchymal necrosis of the liver. A contribution to the knowledge of drug induced lesions of the liver (author's transl)].
    Beckert W
    Zentralbl Allg Pathol; 1973; 117(3):219-26. PubMed ID: 4520112
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract]   [Full Text] [Related]  

  • 5. [Histological follow-up studies on drug induced liver necroses].
    Beckert W
    Z Gesamte Inn Med; 1973 Jul; 28(14):413-7. PubMed ID: 4199479
    [No Abstract]   [Full Text] [Related]  

  • 6. [Medication-induced hepatic lesions in patients with pulmonary tuberculosis].
    Gned'ko NI
    Voen Med Zh; 2002 May; 323(5):56-8. PubMed ID: 12073843
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic involvement in pulmonary tuberculosis. Histologic and functional characteristics.
    Bowry S; Chan CH; Weiss H; Katz S; Zimmerman HJ
    Am Rev Respir Dis; 1970 Jun; 101(6):941-8. PubMed ID: 5419975
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of tuberculosis in patients with pre-existing liver disease or following hepatotoxic drug reactions.
    Robson SC; Pillans P; Willcox PA
    S Afr Med J; 1993 Jun; 83(6):432-4. PubMed ID: 8211464
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lesions of the hepatic parenchyma in patients with chronic pulmonary tuberculosis and miliary tuberculosis; study with liver biopsy; preliminary report].
    FERNANDEZ JJ; AMADOR A; MASFERRER R
    Arch Col Med El Salv; 1955 Dec; 8(4):238-49. PubMed ID: 13314927
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of liver biopsy in the scope of tuberculosis].
    Uehlinger E
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 140(1):224-8. PubMed ID: 5824376
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of liver damage during a course of tuberculosis and chronic pulmonary diseases. Necessity of treatment and new trends].
    Mariani B; Marchioni GF; Capitolo S
    Minerva Med; 1974 Aug; 65(57):2977-89. PubMed ID: 4603931
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatotoxic effect of ethionamide and para-amino-salicylic acid in initial chemotherapy of patients with pulmonary tuberculosis in the light of liver function tests].
    Pruszyńska S
    Gruzlica; 1971 Dec; 39(12):1211-8. PubMed ID: 5139240
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical presentation of miliary tuberculosis with hepatic involvement early after renal transplantation.
    Musumba C; Dey D; Richardson P
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):e52-3. PubMed ID: 23142602
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the problem of chronic liver damage following drug therapy of tuberculosis].
    Petera V; Klapálek D; Paichl P; Pecený A
    Dtsch Z Verdau Stoffwechselkr; 1965 Oct; 25(4):250-2. PubMed ID: 5888913
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in serum transaminase due to prothionamide.
    Somner AR; Brace AA
    Tubercle; 1967 Jun; 48(2):137-43. PubMed ID: 6048656
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
    Narang RK; Singh SK
    Indian J Chest Dis; 1973 Jan; 15(1):16-20. PubMed ID: 4695462
    [No Abstract]   [Full Text] [Related]  

  • 17. [Discriminating evaluation of hepatic damage caused by isoniazid and anicteric viral hepatitis, using enzymatic studies and hepatic biopsy].
    Braito A; Bassetti D
    Pathologica; 1969; 61(897):175-84. PubMed ID: 5314702
    [No Abstract]   [Full Text] [Related]  

  • 18. [Conjugated serum bile acids in chronic liver diseases and cholestasis].
    Frosch B; Wagener H
    Acta Hepatosplenol; 1971; 18(4):273-86. PubMed ID: 5110093
    [No Abstract]   [Full Text] [Related]  

  • 19. [Icteric syndromes in pulmonary tuberculosis. (Etiopathogenesis and differential diagnosis)].
    Del Bono N; Sevieri GP; Leoncini B
    Rass Clin Ter; 1966; 65(6):289-300. PubMed ID: 5997958
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of liver biopsy in the verification of liver involvement in patients with pulmonary tuberculosis].
    Panasek IA; Kolosovskaia VP; Lebedev SP
    Probl Tuberk; 1981 Dec; (12):60-4. PubMed ID: 7335635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.